George Hampton

Executive Vice President, Rheumatology and Primary Care Business Units, Horizon Pharma

George Hampton is the executive vice president of Rheumatology and Primary Care Business Units at Horizon Pharma, where he is tasked with leading the forward-looking strategy, as well as establishing operational goals for both business units. Hampton has more than 20 years of experience as a successful executive in the pharmaceutical and biotech field on both a national and international scale, including specific expertise in rheumatology/autoimmune (HUMIRA), primary care (CELEBREX), orthopedic, diabetes (BYETTA), anti-infectives, and cardiovascular spaces. This includes 10 product launches in roles of increasing responsibility in sales, marketing and operations at G.D. Searle, Abbott Immunology (now AbbVie), and Amylin Pharmaceuticals. Most recently, he served as president and chief executive officer of a privately held technology company.